CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases.
about
Silica, Silicosis, and AutoimmunitySystemic Sclerosis and the Gastrointestinal Tract-Clinical ApproachDose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.Changes of CD4(+) CD25(+) Regulatory T Cells, FoxP3 in Adjuvant Arthritis Rats with Damage of Pulmonary Function and Effects of Tripterygium Glycosides Tablet.Phenotypic, Functional, and Gene Expression Profiling of Peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127(low) Treg Cells in Patients With Chronic Rheumatoid ArthritisAssessment of T regulatory cells and expanded profiling of autoantibodies may offer novel biomarkers for the clinical management of systemic sclerosis and undifferentiated connective tissue disease.CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner.The percentage of FoxP3+Helios+ Treg cells correlates positively with disease activity in systemic lupus erythematosus.Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.Regulatory T Cells in Systemic Sclerosis: a Comprehensive Review.Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia / lymphoma.Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.Treg-enriched CD4+ T cells attenuate collagen synthesis in keloid fibroblasts.[Regulatory T cells and rheumatic diseases].IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.Semaphorin 3A: an immunoregulator in systemic sclerosis
P2860
Q26751007-1E153D31-B172-456E-B597-B02AF2F52866Q28079598-103FA49E-DC5F-4FBC-87A4-8C862F807FFEQ33420837-C5594DED-6CE0-45C6-8145-208A1A5BA374Q36530089-D30BCE4A-32F7-4E71-A87C-A5AD3B2E9CE6Q36800150-48BDC490-BDE3-41BF-944F-8CF65DF1BB2EQ36925590-E783A780-1645-48A2-BA20-E70CA502691CQ37274074-00D5408D-363A-47DE-A61A-8674068DB431Q37475806-CBE8D8D6-C8F5-44C3-950B-75067365C09EQ37627037-E98C6053-3D7C-4069-8988-91A6B52E1D79Q38869606-AF53BDAA-8A28-4126-9CEE-69AAF5599C9BQ45886306-E984DEC5-704B-413D-83EF-00F548E589B5Q46774503-EF409B17-11E2-4EA2-AB98-786372437FCCQ46816215-CBC78643-8291-4ED2-AC25-47A14CD0EB5BQ48881731-985B794A-3165-469E-96FE-5F0F019F55BBQ52869751-6DFE4AE5-8044-4339-BEA5-8F422670DC9CQ53467545-8D6F80A7-1B74-4B5B-BB29-6AE9698FE3E3Q58040981-077BCF3B-130A-479D-A33E-12B627E5377B
P2860
CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases.
@en
CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases.
@nl
type
label
CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases.
@en
CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases.
@nl
prefLabel
CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases.
@en
CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases.
@nl
P2860
P356
P1476
CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases.
@en
P2093
Gina J Walter
Jocea M R Michels-van Amelsfort
P2860
P304
P356
10.1586/ECI.11.28
P577
2011-07-01T00:00:00Z